WEST PHARMACEUTICAL SERVICES (WST:NYSE)
$328.84 -1.5 (-0.4541%)
Analysed WEST PHARMACEUTICAL SERVICES (WST:NYSE) News Sources
AMN Expands Language Services Portfolio With Jaide Health Deal
10-06-2026
yahoo.com
Here's Why You Should Add NeuroPace Stock to Your Portfolio Now
10-06-2026
yahoo.com
Reasons to Add Veeva Systems Stock to Your Portfolio for Now
10-06-2026
yahoo.com
TXG Gains From Proteintech Deal, Expands Multiomics Capabilities
10-06-2026
yahoo.com
Hinge Health Expands HingeSelect to Offer End-to-End MSK Surgical Care
11-06-2026
yahoo.com
Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership
11-06-2026
yahoo.com
Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19
12-06-2026
yahoo.com
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
12-06-2026
yahoo.com
Veeva Expands Safety Suite Footprint With UCB Pharmacovigilance Deal
12-06-2026
yahoo.com
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
12-06-2026
yahoo.com
What is the current price of WEST PHARMACEUTICAL SERVICES (WST:NYSE)?
The current price of WEST PHARMACEUTICAL SERVICES (WST:NYSE) is $328.84.
WEST PHARMACEUTICAL SERVICES (WST:NYSE) absolute price change since previous trading day?
The absolute price change of WEST PHARMACEUTICAL SERVICES (WST:NYSE) since the previous trading day is $-1.5.
WEST PHARMACEUTICAL SERVICES (WST:NYSE) percentage price change since previous trading day?
The percentage price change of WEST PHARMACEUTICAL SERVICES (WST:NYSE) since the previous trading day is -0.4541%.
What is the most recent average sentiment score for WEST PHARMACEUTICAL SERVICES (WST:NYSE)?
The most recent average sentiment score for WEST PHARMACEUTICAL SERVICES (WST:NYSE) is 76 out of 100.
What is the most recent average sentiment for WEST PHARMACEUTICAL SERVICES (WST:NYSE)?
The most recent sentiment for WEST PHARMACEUTICAL SERVICES (WST:NYSE) is .
SEC-8K** Filing Available For WEST PHARMACEUTICAL SERVICES (WST:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.